Guardant Health, Inc.
GHDiagnostics & Research
$185.31+1.49%As of Oct 29vs prior close
- Market cap
- $24.9B
- P/E (TTM)
- –
- From 52W high
- −1.02%
- EPS (LTM)
- -$3.50
- Revenue (LTM)
- $1.2B
- Net margin
- -38.33%
- Dividend yield
- 0.00%
Nomior Score
49
Ascendant MoverBottom 48% of the scored universe
Growth71
Quality25
Value25
Momentum88
Resilience41
Growth
+45.15%revenue a year over 8 fiscal years
YE17 $49.8MLTM $1.2B
Connections
Revenue to profitQ2 YE26
The operating loss was 39% of revenue, narrower by 7 pts on a year.
Who owns it
1fund, 1 tracked portfolio